References
- Lee KA, Baker FC. Sleep and women's health across the lifespan. Sleep Med Clin 2018;13:xv–xvi
- Zhang B, Wing Y-K. Sex differences in insomnia: a meta-analysis. Sleep 2006;29:85–93
- American Academy of Sleep Medicine. International classification of sleep disorders-third edition (ICSD-3). Darien, IL: American Academy of Sleep Medicine; 2014
- Edinger JD, Bonnet MH, Bootzin RR, et al. Derivation of research diagnostic criteria for insomnia: report of an American Academy of Sleep Medicine Work Group. Sleep 2004;27:1567–96
- Khan MS, Aouad R. The effects of insomnia and sleep loss on cardiovascular disease. Sleep Med Clin 2017;12:167–77
- Morin CM, LeBlanc M, Daley M, et al. Epidemiology of insomnia: prevalence, self-help treatments, consultations, and determinants of help-seeking behaviors. Sleep Med 2006;7:123–30
- Baker FC, Lampio L, Saaresranta T, et al. Sleep and sleep disorders in the menopausal transition. Sleep Med Clin 2018;13:443–56
- Xu Q, Lang CP, Rooney N. A systematic review of the longitudinal relationships between subjective sleep disturbance and menopausal stage. Maturitas 2014;79:401–12
- Bruyneel M. Sleep disturbances in menopausal women: aetiology and practical aspects. Maturitas 2015;81:406–9
- Gold EB, Sternfeld B, Kelsey JL, et al. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40–55 years of age. Am J Epidemiol 2000;152:463–73
- Joffe H, Massler A, Sharkey KM. Evaluation and management of sleep disturbance during the menopause transition. Semin Reprod Med 2010;28:404–21
- Guidozzi F. Sleep and sleep disorders in menopausal women. Climacteric 2013;16:214–19
- Kravitz HM, Joffe H. Sleep during the perimenopause: a SWAN story. Obstet Gynecol Clin North Am 2011;38:567–86
- Wesstrom J, Nilsson S, Sundstrom-Poromaa I, et al. Restless legs syndrome among women: prevalence, co-morbidity and possible relationship to menopause. Climacteric 2008;11:422–8
- Galvan T, Camuso J, Sullivan K, et al. Association of estradiol with sleep apnea in depressed perimenopausal and postmenopausal women: a preliminary study. Menopause 2017;24:112–17
- Zolfaghari S, Yao C, Thompson C, et al. Effects of menopause on sleep quality and sleep disorders. Canadian Longitudinal Study on Aging. Menopause 2019;27:295–304
- Kravitz HM, Ganz PA, Bromberger J, et al. Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition. Menopause 2003;10:19–28
- El Khoudary SR, Greendale G, Crawford SL, et al. The menopause transition and women's health at midlife: a progress report from the Study of Women's Health Across the Nation (SWAN). Menopause 2019;26:1213–27
- Blümel JE, Chedraui P, Baron G, et al. Menopausal symptoms appear before the menopause and persist 5 years beyond: a detailed analysis of a multinational study. Climacteric 2012;15:542–51
- LeBlanc M, Mérette C, Savard J, et al. Incidence and risk factors of insomnia in a population-based sample. Sleep 2009;32:1027–37
- Freeman EW, Sammel MD, Gross SA, et al. Poor sleep in relation to natural menopause: a population-based 14-year follow-up of midlife women. Menopause 2015;22:719–26
- Kravitz HM, Zhao X, Bromberger JT, et al. Sleep disturbance during the menopausal transition in a multi-ethnic community sample of women. Sleep 2008;31:979–90
- Woods NF, Mitchell ES. Sleep symptoms during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women’s Health Study. Sleep 2010;33:539–49
- Lampio L, Polo-Kantola P, Polo O, et al. Sleep in midlife women: effects of menopause, vasomotor symptoms, and depressive symptoms. Menopause 2014;21:1217–24
- Yazdi Z, Sadeghniiat-Haghighi K, Ziaee A, et al. Influence of sleep disturbances on quality of life of Iranian menopausal women. Psychiatry J 2013;2013:907068
- Cray LA, Woods NF, Herting JR, et al. Symptom clusters during the late reproductive stage through the early postmenopause: observations from the Seattle Midlife Women's Health Study. Menopause 2012;19:864–9
- Brown JP, Gallicchio L, Flaws JA, et al. Relations among menopausal symptoms, sleep disturbance and depressive symptoms in midlife. Maturitas 2009;62:184–9
- Javaheri S, Redline S. Insomnia and risk of cardiovascular disease. Chest 2017;152:435–44
- Da Fonseca AM, Bagnoli VR, Souza MA, et al. Impact of age and body mass on the intensity of menopausal symptoms in 5968 Brazilian women. Gynecol Endocrinol 2013;29:116–18
- Carrier J, Semba K, Deurveilher S, et al. Sex differences in age-related changes in the sleep-wake cycle. Front Neuroendocrinol 2017;47:66–85
- Deurveilher S, Seary ME, Semba K. Ovarian hormones promote recovery from sleep deprivation by increasing sleep intensity in middle-aged ovariectomized rats. Horm Behav 2013;63:566–76
- de Zambotti M, Colrain IM, Baker FC. Interaction between reproductive hormones and physiological sleep in women. J Clin Endocrinol Metab 2015;100:1426–33
- Manber R, Armitage R. Sex, steroids, and sleep: a review. Sleep 1999;22:540–55
- Gervais NJ, Mong JA, Lacreuse A. Ovarian hormones, sleep and cognition across the adult female lifespan: an integrated perspective. Front Neuroendocrinol 2017;47:134–53
- Freedman RR, Woodward S. Core body temperature during menopausal hot flushes. Fertil Steril 1996;65:1141–4
- Kische H, Ewert R, Fietze I, et al. Sex hormones and sleep in men and women from the general population: a cross-sectional observational study. J Clin Endocrinol Metab 2016;101:3968–77
- Sowers MR, Eyvazzadeh AD, McConnell D, et al. Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition. J Clin Endocrinol Metab 2008;93:3478–83
- Avis NE, Crawford SL, Greendale G, et al. Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Intern Med 2015;175:531–9
- Pinkerton JV, Abraham L, Bushmakin AG, et al. Relationship between changes in vasomotor symptoms and changes in menopause-specific quality of life and sleep parameters. Menopause 2016;23:1060–6
- Bonanni E, Schirru A, Di Perri MC, et al. Insomnia and hot flashes. Maturitas 2019;126:51–4
- Ohayon MM. Severe hot flashes are associated with chronic insomnia. Arch Intern Med 2006;166:1262–8
- Campbell SS, Murphy PJ. The nature of spontaneous sleep across adulthood. J Sleep Res 2007;16:24–32
- de Zambotti M, Colrain IM, Javitz HS, et al. Magnitude of the impact of hot flashes on sleep in perimenopausal women. Fertil Steril 2014;102:1708–15.e1
- Bianchi MT, Kim S, Galvan T, et al. Nocturnal Hot Flashes: relationship to Objective Awakenings and Sleep Stage Transitions. J Clin Sleep Med 2016;12:1003–9
- Polo-Kantola P. Sleep problems in midlife and beyond. Maturitas 2011;68:224–32
- Thurston RC, Bromberger JT, Joffe H, et al. Beyond frequency: who is most bothered by vasomotor symptoms? Menopause 2008;15:841–7
- Achermann P. The two-process model of sleep regulation revisited. Aviat Space Environ Med 2004;75:A37–43
- Tordjman S, Chokron S, Delorme R, et al. Melatonin: pharmacology, Functions and Therapeutic Benefits. Curr Neuropharmacol 2017;15:434–43
- Walters JF, Hampton SM, Ferns G, Skene DJ. Effect of menopause on melatonin and alertness rhythms investigated in constant routine conditions. Chronobiol Int 2005;22:859–72
- Mong JA, Cusmano DM. Sex differences in sleep: impact of biological sex and sex steroids. Philos Trans R Soc Lond, B, Biol Sci 2016;371:20150110
- Toffol E, Kalleinen N, Haukka J, et al. Melatonin in perimenopausal and postmenopausal women: associations with mood, sleep, climacteric symptoms, and quality of life. Menopause 2014;21:493–500
- Parry BL, Meliska CJ, Martínez LF, et al. Late, but not early, wake therapy reduces morning plasma melatonin: relationship to mood in Premenstrual Dysphoric Disorder. Psychiatry Res 2008;161:76–86
- Carranza-Lira S, García López F. Melatonin and climactery. Med Sci Monit Int Med J Exp Clin Res 2000;6:1209–12
- Cagnacci A. Role of melatonin in circadian rhythm at menopause. Climacteric 2017;20:183
- Hardeland R, Cardinali DP, Srinivasan V, et al. Melatonin-a pleiotropic, orchestrating regulator molecule. Prog Neurobiol 2011;93:350–84
- Hajali V, Andersen ML, Negah SS, et al. Sex differences in sleep and sleep loss-induced cognitive deficits: the influence of gonadal hormones. Horm Behav 2019;108:50–61
- Guarnieri B. Sleep disorders and cognitive alterations in women. Maturitas 2019;126:25–7
- Silvestri R, Aricò I, Bonanni E, et al. Italian Association of Sleep Medicine (AIMS) position statement and guideline on the treatment of menopausal sleep disorders. Maturitas 2019;129:30–9
- Caretto M, Giannini A, Simoncini T. An integrated approach to diagnosing and managing sleep disorders in menopausal women. Maturitas 2019;128:1–3
- Jarrin DC, Chen IY, Ivers H, et al. The role of vulnerability in stress-related insomnia, social support and coping styles on incidence and persistence of insomnia. J Sleep Res 2014;23:681–8
- Kline CE, Irish LA, Krafty RT, et al. Consistently high sports/exercise activity is associated with better sleep quality, continuity and depth in midlife women: the SWAN sleep study. Sleep 2013;36:1279–88
- Riemann D, Baglioni C, Bassetti C, et al. European guideline for the diagnosis and treatment of insomnia. J Sleep Res 2017;26:675–700
- Morin CM, Vallières A, Guay B, et al. Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial. JAMA 2009;301:2005–15
- McCurry SM, Guthrie KA, Morin CM, et al. Telephone-based cognitive behavioral therapy for insomnia in perimenopausal and postmenopausal women with vasomotor symptoms: a MsFLASH randomized clinical trial. JAMA Intern Med 2016;176:913–20
- Guthrie KA, Larson JC, Ensrud KE, et al. Effects of pharmacologic and nonpharmacologic interventions on insomnia symptoms and self-reported sleep quality in women with hot flashes: a pooled analysis of individual participant data from four MsFLASH trials. Sleep 2018; 41:41
- Drake CL, Kalmbach DA, Arnedt JT, et al. Treating chronic insomnia in postmenopausal women: a randomized clinical trial comparing cognitive-behavioral therapy for insomnia, sleep restriction therapy, and sleep hygiene education. Sleep 2019;42:42
- Baber RJ, Panay N, Fenton A, 2016 IMS Recommendations on women's midlife health and menopause hormone therapy. Climacteric 2016;19:109–50
- Hays J, Ockene JK, Brunner RL, et al. Effects of estrogen plus progestin on health-related quality of life. N Engl J Med 2003;348:1839–54
- Saletu-Zyhlarz G, Anderer P, Gruber G, et al. Insomnia related to postmenopausal syndrome and hormone replacement therapy: sleep laboratory studies on baseline differences between patients and controls and double-blind, placebo-controlled investigations on the effects of a novel estrogen-progestogen combination (Climodien, Lafamme) versus estrogen alone. J Sleep Res 2003;12:239–54
- Sherman AM, Shumaker SA, Sharp P, et al. No effect of HRT on health-related quality of life in postmenopausal women with heart disease. Minerva Ginecol 2003;55:511–17
- Heinrich AB, Wolf OT. Investigating the effects of estradiol or estradiol/progesterone treatment on mood, depressive symptoms, menopausal symptoms and subjective sleep quality in older healthy hysterectomized women: a questionnaire study. Neuropsychobiology 2005;52:17–23
- Kalleinen N, Polo O, Himanen S-L, et al. Sleep deprivation and hormone therapy in postmenopausal women. Sleep Med 2006;7:436–47
- Cintron D, Lipford M, Larrea-Mantilla L, et al. Efficacy of menopausal hormone therapy on sleep quality: systematic review and meta-analysis. Endocrine 2017;55:702–11
- Savolainen-Peltonen H, Hautamäki H, Tuomikoski P, et al. Health-related quality of life in women with or without hot flashes: a randomized placebo-controlled trial with hormone therapy. Menopause 2014;21:732–9
- Cintron D, Lahr BD, Bailey KR, et al. Effects of oral versus transdermal menopausal hormone treatments on self-reported sleep domains and their association with vasomotor symptoms in recently menopausal women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS). Menopause 2018;25:145–53
- LeBlanc ES, Neiss MB, Carello PE, et al. Hot flashes and estrogen therapy do not influence cognition in early menopausal women. Menopause 2007;14:191–202
- Empson JA, Purdie DW. Effects of sex steroids on sleep. Ann Med 1999;31:141–5
- Antonijevic IA, Stalla GK, Steiger A. Modulation of the sleep electroencephalogram by estrogen replacement in postmenopausal women. Am J Obstet Gynecol 2000;182:277–82
- Prior JC. Progesterone for treatment of symptomatic menopausal women. Climacteric 2018;21:358–65
- Polo-Kantola P, Erkkola R, Irjala K, et al. Effect of short-term transdermal estrogen replacement therapy on sleep: a randomized, double-blind crossover trial in postmenopausal women. Fertil Steril 1999;71:873–80
- Polo-Kantola P, Erkkola R, Helenius H, et al. When does estrogen replacement therapy improve sleep quality?. Am J Obstet Gynecol 1998;178:1002–9
- Grady D, Yaffe K, Kristof M, et al. Effect of postmenopausal hormone therapy on cognitive function: the heart and estrogen/progestin replacement study. Am J Med 2002;113:543–8
- Geiger PJ, Eisenlohr-Moul T, Gordon JL, et al. Effects of perimenopausal transdermal estradiol on self-reported sleep, independent of its effect on vasomotor symptom bother and depressive symptoms. Menopause 2019;26:1318–23
- Vinogradova Y, Coupland C, Hippisley-Cox J. Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ 2019;364:k4810
- Thomas AJ, Ismail R, Taylor-Swanson L, et al. Effects of isoflavones and amino acid therapies for hot flashes and co-occurring symptoms during the menopausal transition and early postmenopause: a systematic review. Maturitas 2014;78:263–76
- Biglia N, Bounous VE, De Seta F, et al. Non-hormonal strategies for managing menopausal symptoms in cancer survivors: an update. Ecancermedicalscience 2019;13:909
- Attarian H, Hachul H, Guttuso T, et al. Treatment of chronic insomnia disorder in menopause: evaluation of literature. Menopause 2015;22:674–84
- Ensrud KE, Joffe H, Guthrie KA, et al. Effect of escitalopram on insomnia symptoms and subjective sleep quality in healthy perimenopausal and postmenopausal women with hot flashes: a randomized controlled trial. Menopause 2012;19:848–55
- DeFronzo Dobkin R, Menza M, Allen LA, et al. Escitalopram reduces hot flashes in nondepressed menopausal women: a pilot study. Ann Clin Psychiatry 2009;21:70–6
- Davari-Tanha F, Soleymani-Farsani M, Asadi M, et al. Comparison of citalopram and venlafaxine’s role in treating sleep disturbances in menopausal women, a randomized, double-blind, placebo-controlled trial. Arch Gynecol Obstet 2016;293:1007–13
- Suvanto-Luukkonen E, Koivunen R, Sundström H, et al. Citalopram and fluoxetine in the treatment of postmenopausal symptoms: a prospective, randomized, 9-month, placebo-controlled, double-blind study. Menopause 2005;12:18–26
- Dolev Z. Case series of perimenopausal women with insomnia treated with mirtazapine followed by prolonged-release melatonin add-on and monotherapy. Arch Womens Ment Health 2011;14:269–73
- Birkhaeuser M, Bitzer J, Braat S, et al. Esmirtazapine treatment of postmenopausal vasomotor symptoms: two randomized controlled trials. Climacteric 2019;22:312–22
- Bellipanni G, Bianchi P, Pierpaoli W, et al. Effects of melatonin in perimenopausal and menopausal women: a randomized and placebo controlled study. Exp Gerontol 2001;36:297–310
- Bellipanni G, DI Marzo F, Blasi F, et al. Effects of melatonin in perimenopausal and menopausal women: our personal experience. Ann N Y Acad Sci 2005;1057:393–402
- Gursoy AY, Kiseli M, Caglar GS. Melatonin in aging women. Climacteric 2015;18:790–6
- Wade AG, Crawford G, Ford I, et al. Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response. Curr Med Res Opin 2011;27:87–98
- Wilson SJ, Nutt DJ, Alford C, et al. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. J Psychopharmacol (Oxford) 2010;24:1577–601
- Arbon EL, Knurowska M, Dijk D-J. Randomised clinical trial of the effects of prolonged-release melatonin, temazepam and zolpidem on slow-wave activity during sleep in healthy people. J Psychopharmacol (Oxford) 2015;29:764–76
- Lemoine P, Nir T, Laudon M, et al. Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects. J Sleep Res 2007;16:372–80
- Otmani S, Demazières A, Staner C, et al. Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers. Hum Psychopharmacol 2008;23:693–705
- Otmani S, Metzger D, Guichard N, et al. Effects of prolonged-release melatonin and zolpidem on postural stability in older adults. Hum Psychopharmacol 2012;27:270–6
- Wilson S, Anderson K, Baldwin D, et al. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: an update. J Psychopharmacol (Oxford) 2019;33:923–47
- Palagini L. Expert opinions and consensus recommendations for the evaluation and management of insomnia in clinical practice: joint statements of Five Italian scientific societies. Front Psychiatry 2020;11
- Jehan S, Jean-Louis G, Zizi F, et al. Sleep, melatonin, and the menopausal transition: what are the links? Sleep Sci Sao Paulo Braz 2017;10:11–18
- Jehan S, Masters-Isarilov A, Salifu I, et al. Sleep disorders in postmenopausal women. J Sleep Disord Ther 2015;4:1000212
- Pandi-Perumal SR, Srinivasan V, Spence DW, et al. Ramelteon: a review of its therapeutic potential in sleep disorders. Adv Ther 2009;26:613–26
- Mayer G, Wang-Weigand S, Roth-Schechter B, et al. Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia. Sleep 2009;32:351–60
- Richardson G, Wang-Weigand S. Effects of long-term exposure to ramelteon, a melatonin receptor agonist, on endocrine function in adults with chronic insomnia. Hum Psychopharmacol 2009;24:103–11
- Dorsey CM, Lee KA, Scharf MB. Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study. Clin Ther 2004;26:1578–86
- Soares CN, Joffe H, Rubens R, et al. Eszopiclone in patients with insomnia during perimenopause and early postmenopause: a randomized controlled trial. Obstet Gynecol 2006;108:1402–10
- Joffe H, Petrillo L, Viguera A, et al. Eszopiclone improves insomnia and depressive and anxious symptoms in perimenopausal and postmenopausal women with hot flashes: a randomized, double-blinded, placebo-controlled crossover trial. Am J Obstet Gynecol 2010;202:171.e1–171.e11
- Kripke DF, Langer RD, Kline LE. Hypnotics’ association with mortality or cancer: a matched cohort study. BMJ Open 2012;2:e000850
- Xing D, Ma XL, Ma JX, et al. Association between use of benzodiazepines and risk of fractures: a meta-analysis. Osteoporos Int 2014;25:105–20
- Treves N, Perlman A, Kolenberg Geron L, et al. Z-drugs and risk for falls and fractures in older adults-a systematic review and meta-analysis. Age Ageing 2018;47:201–8
- Luz Rentero M, Carbonell C, Casillas M, et al. Risk factors for osteoporosis and fractures in postmenopausal women between 50 and 65 years of age in a primary care setting in Spain: a questionnaire. Open Rheumatol J 2008;2:58–63
- Babalonis S, Lile JA, Martin CA, et al. Physiological doses of progesterone potentiate the effects of triazolam in healthy, premenopausal women. Psychopharmacology (Berl) 2011;215:429–39
- Loprinzi L, Barton DL, Sloan JA, et al. Pilot evaluation of gabapentin for treating hot flashes. Mayo Clin Proc 2002;77:1159–63
- Yurcheshen ME, Guttuso T, McDermott M, et al. Effects of gabapentin on sleep in menopausal women with hot flashes as measured by a Pittsburgh Sleep Quality Index factor scoring model. J Womens Health (Larchmt) 2009;18:1355–60
- Guttuso T. Nighttime awakenings responding to gabapentin therapy in late premenopausal women: a case series. J Clin Sleep Med 2012;8:187–9